On November 4, 2020 at the virtual AAPS conference, the role of model informed drug development practices as applied to COVID was discussed by Dr. Craig Rayner, President of Integrated Drug Developmen...

As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions, there is a pressing need to accelerate treatment evaluations. Among ...

Pharmaceutical research and development is organized around prioritized investments, delivering on assets with the greatest return of investments. Linear sequencing of trials and financial risks are d...

Controlled Human Infection Challenge Studies which involve the deliberate infection of healthy volunteers are well established during the clinical development of vaccines for influenza, typhoid, chole...

Here’s a great quick and easy video overview of the drugs which are being tested for COVID-19 treatment from PharmaPro Consulting.  

This commentary in Lancet discusses the need to understand the various disease states of COVID-19  when interpreting trial results. The majority of  clinical trials involve patients who have been ad...

Certara has launched the COVID-19 Clinical Outcomes Database to provide up-to-date information on the results of COVID-19 clinical trials and observational studies, worldwide. The database captures pu...

The British Pharmacological Society and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists published a joint statement in the British Journal of Clinical Pharmacol...

With a vaccine likely a year or longer away, there is urgency around determining the right therapeutic at the right dose to fight COVID-19. Results from clinical trials of monotherapies have been a mi...

A COVID-19 call to action in Clinical Pharmacology & Therapeutics from Richard Peck, Daniel Weiner, Jack Cook and Bob Powell. “The Global Heads of Clinical Pharmacology from the pharmaceutic...